Cargando…

Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications

New oral anticoagulants, including dabigatran, rivaroxaban, and apixaban, have been recently approved for primary and secondary prophylaxis of thromboembolic conditions. However, there is no clear strategy for managing and reversing their anticoagulant effects. We aimed to summarize the available ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazo-Langner, Alejandro, Lang, Eddy S, Douketis, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707037/
https://www.ncbi.nlm.nih.gov/pubmed/23806169
http://dx.doi.org/10.1186/cc12592

Ejemplares similares